The Innovative Medicines Initiative: an engine for regulatory science
- PMID: 25503331
- DOI: 10.1038/nrd4520
The Innovative Medicines Initiative: an engine for regulatory science
Abstract
Since its launch in 2008, the Innovative Medicines Initiative has catalysed the formation of many consortia to address challenges in drug development and regulation. As it moves into its second phase, we highlight key outcomes so far and the lessons learned.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
